Professor Gilles Karcher (PhD, MD) is a SUPELEC engineer and physician specialist in nuclear medicine. He is a professor of biophysics at the University of Lorraine and professor of nuclear medicine at the University Hospital of Nancy. Gilles Karcher is currently Head of the Department of Nuclear Medicine and the Imaging Division of the University Hospital of Nancy. He is responsible for the creation of Nancylotep with the aim of making the latter a tool for accelerating the transfer of research to clinical applications in nuclear medicine, and in particular for the implementation of new radiopharmaceuticals.

Marjorie Fougère (PhD), engineer and doctor in life sciences, joined Nancyclotep as General Manager in June 2018. Previously, Marjorie assisted Greater East companies in their innovation projects within the Regional Council. Marjorie also worked as a junior scientist in a biotechnology company.

Pierre-Yves Marie (PhD, MD), specialist in nuclear medicine, MRI and cardiovascular diseases, is a University professor and hospital practitioner (PU-PH) in nuclear medicine, and current Vice-President of Research and Head of the Research Support Facilities Pole at the University Hospital of Nancy. Recognized for his experience and research work, Pierre-Yves Marie has been the scientific director of Nancyclotep since its creation.

Fatiha Maskali (PhD), biologist and expert in radioisotopic imaging in animals, member of the Lorraine Ethics Committee, joined Nancyclotep at its creation and spearheaded the creation of the Preclinical Imaging Platform (PRIPA) that she currently heads.

Charlotte Collet (PhD), a specialist in organic chemistry, joined Nancyclotep in 2013. She established the radiochemistry laboratory which she currently heads. She was appointed Research Engineer at the University of Lorraine in 2016 in the IADI laboratory.

Véronique Roch (MSc, Bioengineering Medicines and NanoHealth) is a hospital engineer at the University Hospital of Nancy. She has been present at Nancyclotep since its creation. Previously a clinical studies technician, she has been a project manager since 2015 and actively participates with nuclear physicians in the drafting of clinical research projects.

Aurélien Duquesne (PharmD, MSc) is a Pharmacist and Chemical Industries Engineer. He joined Nancyclotep in May 2020. Aurélien also worked for several companies in the field of sterile injectable pharmaceutical products. Before joining Nancyclotep, Aurélien worked in the field of radiopharmaceuticals for Advanced Accelerator Applications as assistant pharmacist and site quality assurance manager.